News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • BOSS Zhipin Q2 revenue rose 14.1% YoY and operating income jumped 32.6%, and firm announced ~$230M dividend plus $300M+ buybacks.
  • Vicor reports backlog growth and margin expansion, positioning it for AI power demand and potential revenue and free-cash-flow upside.
  • Brookfield priced $600M senior notes due 2031 at 5.65% to fund general corporate purposes, closing expected Sept 23.
  • Woodward will shift aerospace controls production from Santa Clarita to Spartanburg, affecting roughly 400 jobs and selling the legacy facility by FY2027.
  • Analyst initiates Buy on Cue Biopharma after a positive CUE-221 CSU readout, recommending a tactical entry and a 45-day $45 target.
  • Helus Pharma CEO to appear at the TD Cowen neuropsychiatry summit, spotlighting serotonergic agonists and FDA Breakthrough Therapy status for HLP003.

Latest Articles

Teck Resources Shares Jump After Q2 Results Top Estimates

Teck Resources Shares Jump After Q2 Results Top Estimates

Teck Resources Ltd Class B stock climbed in pre-market trading after the Vancouver-based miner posted second-quarter results that exceeded analyst expectations on both the top and bottom line. Strong operational execution drove a sharp rise in adjusted EBITDA and profit, while management cited steady performance at its QB copper mine and noted prog…

IMAX Shares Jump After Q2 Beat and 'The Odyssey' Boost Premium Screen Demand

IMAX Shares Jump After Q2 Beat and 'The Odyssey' Boost Premium Screen Demand

IMAX Corp's stock climbed sharply in pre-market trading after reporting second-quarter 2026 results that topped analyst expectations on both revenue and adjusted earnings. The beat was reinforced by exceptional North American box office performance from Christopher Nolan's 'The Odyssey', which set multiple IMAX records and helped push demand for pr…

Skyworks Introduces New NetSync™ Network Synchronizers Available Now For AI Data Centers and Time-Sensitive Infrastructure

Skyworks Introduces New NetSync™ Network Synchronizers Available Now For AI Data Centers and Time-Sensitive Infrastructure

Skyworks Solutions, Inc. has introduced the SKY6911x/2x family of NetSync™ network synchronizers designed for AI data centers and time-sensitive communication infrastructure. These devices integrate network synchronization, ultra-low jitter clocking, and support high-speed data rates up to 1.6T, simplifying system design and accelerating integratio…

Kratos Defense & Security Solutions Schedules Second Quarter 2026 Earnings Conference Call for Tuesday, August 4th

Kratos Defense & Security Solutions Schedules Second Quarter 2026 Earnings Conference Call for Tuesday, August 4th

Kratos Defense & Security Solutions, a Nasdaq-listed defense technology company, announced it will publish its Q2 2026 financial results after market close on August 4th, 2026, followed by a management conference call. The company specializes in technologies and products for defense, national security, and commercial markets, focusing on affordable…

YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services

YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services

YD Bio Limited and its affiliate EG BioMed Co., Ltd. highlighted significant advancements in ophthalmologic treatments, including the commercial readiness of preservative-free artificial tears and ongoing development of limbal stem cell exosome therapy. EG BioMed expanded its US-based oncology diagnostics services to 47 states, enhancing DNA methyl…

Karat Packaging to Report 2026 Second Quarter Financial Results and Host Conference Call on Thursday, August 6, 2026

Karat Packaging to Report 2026 Second Quarter Financial Results and Host Conference Call on Thursday, August 6, 2026

Karat Packaging Inc., a manufacturer and distributor of eco-friendly disposable foodservice products, will release its second quarter 2026 financial results after market close on August 6, 2026, followed by an investor conference call. The company serves national and regional restaurants across the U.S. and offers sustainable product lines and cust…

Cass Information Systems reports Second Quarter 2026 Results

Cass Information Systems reports Second Quarter 2026 Results

Cass Information Systems, Inc. reported record net income and EPS for Q2 2026, driven by increased net interest margin, higher transportation dollar volumes, strong asset quality, and disciplined expense management. The company benefits from favorable market conditions including rising freight rates and a sustained higher interest rate environment,…

Refinity Selects Zeton to Design and Build Modular Plastic-to-Olefins Plant to Serve as a Repeatable Model for Commercial Deployment

Refinity Selects Zeton to Design and Build Modular Plastic-to-Olefins Plant to Serve as a Repeatable Model for Commercial Deployment

Innventure's subsidiary, Refinity, announced it has engaged Zeton Inc. to design and construct a 10,000-tonne modular demonstration plant that converts hard-to-recycle mixed plastic waste directly into ethylene and propylene olefins. This modular facility aims to serve as a scalable commercial model adjacent to third-party petrochemical steam crack…

HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027

HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027

HCW Biologics announced it has requested a Type B pre-IND meeting with the U.S. FDA to discuss development and regulatory strategies for its lead tetravalent T-cell engager candidate, HCW11-018b. This investigational immunotherapeutic shows promise in treating solid tumors by targeting tissue factor-expressing cancer cells, with demonstrated precli…

PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million

PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million

PetMed Express, Inc., operating as PetMeds, announced a proposed $37 million sale-leaseback transaction involving its headquarters and distribution center buildings in Delray Beach, Florida. The sale is subject to customary closing conditions and due diligence, with the company planning to lease back the facilities to maintain operations. The trans…

Portillo’s Appoints Christopher Hansen as Executive Chef and Senior Director of Culinary Innovation

Portillo’s Appoints Christopher Hansen as Executive Chef and Senior Director of Culinary Innovation

Portillo's, the Chicago-based fast-casual restaurant chain, has appointed Christopher Hansen as Executive Chef and Senior Director of Culinary Innovation. Hansen brings over 30 years of culinary leadership and will oversee menu strategy to honor the brand's heritage while introducing new offerings, supporting national expansion and enhanced guest e…

Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH

Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH

Inhibikase Therapeutics announced that the FDA has granted Orphan Drug Designation to its lead product candidate IKT-001, a prodrug of imatinib mesylate, for treating Pulmonary Arterial Hypertension (PAH). This designation recognizes the unmet medical need in PAH, affects around 50,000 US patients, and provides regulatory incentives including poten…

GPGI Announces Date of Second Quarter 2026 Earnings Call

GPGI Announces Date of Second Quarter 2026 Earnings Call

GPGI, Inc., a multi-industry diversified platform listed on NYSE as GPGI, announced that it will host a conference call to discuss its second quarter 2026 financial results on August 6, 2026. The event will include a live webcast and a Q&A session with the leadership team. GPGI operates notable businesses such as CompoSecure and Husky under the man…